The effect of herbal medicine baicalin on pharmacokinetics of rosuvastatin, substrate of organic anion-transporting polypeptide 1B1

被引:70
作者
Fan, L. [1 ]
Zhang, W. [1 ]
Guo, D. [1 ]
Tan, Z-R [1 ]
Xu, P. [2 ]
Li, Q. [1 ]
Liu, Y-Z [1 ]
Zhang, L. [1 ]
He, T-Y [1 ]
Hu, D-L [1 ]
Wang, D. [1 ]
Zhou, H-H [1 ]
机构
[1] Cent S Univ, Pharmacogenet REs Inst, Inst Clin Pharmacol, Changsha, Hunan, Peoples R China
[2] Cent S Univ, Affiliated Hosp 2, XiangYa Med Sch, Changsha, Hunan, Peoples R China
关键词
D O I
10.1038/sj.clpt.6100318
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The aim of this study was to explore potential herb-drug interaction between baicalin and rosuvastatin, a typical substrate for organic anion-transporting polypeptide 1B1 (OATP1B1) related to different OATP1B1 haplotype groups. Eighteen unrelated healthy volunteers who were CYP2C9*1/*1 with different OATP1B1 haplotypes (six OATP1B1*1b/*1b, six OATP1B1*1b/* 15, and six OATP1B1*15/*15) were selected to participate in this study. Rosuvastatin (20mg orally) pharmacokinetics after coadministration of placebo and 50-mg baicalin tablets (three times daily orally for 14 days) were measured for up to 72 h by liquid chromatography-mass spectrometry in a two-phase randomized crossover study. After baicalin treatment, the area under the plasma concentration-time curve (AUC)((0-72)) and AUC((0-infinity)) of rosuvastatin decreased by 47.0 +/- 11.0% (P=0.001) and 41.9 +/- 7.19% (P=0.001) in OATP1B1*1b/*1b, 21.0 +/- 20.6% (P=0.035) and 23.9 +/- 8.66% (P=0.004) in OATP1B1*1b/* 15, and 9.20 +/- 11.6% (P=0.077) and 1.76 +/- 4.89% (P=0.36) in OATP1B1*15/*15, respectively. Moreover, decreases of both AUC((0-72)) and AUC((0-infinity)) of rosuvastatin among different haplotype groups were significantly different (P=0.002 and <0.001). Baicalin reduces plasma concentrations of rosuvastatin in an OATP1B1 haplotype-dependent manner.
引用
收藏
页码:471 / 476
页数:6
相关论文
共 44 条
[1]
ABE K, 1990, CHEM PHARM BULL, V38, P208, DOI 10.1248/cpb.38.208
[2]
Balicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form [J].
Akao, T ;
Kawabata, K ;
Yanagisawa, E ;
Ishihara, K ;
Mizuhara, Y ;
Wakui, Y ;
Sakashita, Y ;
Kobashi, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2000, 52 (12) :1563-1568
[3]
Biliary secretion of rosuvastatin and bile acids in humans during the absorption phase [J].
Bergman, Ebba ;
Forsell, Patrik ;
Tevell, Annica ;
Persson, Eva M. ;
Hedeland, Mikael ;
Bondesson, Ulf ;
Knutson, Lars ;
Lennernas, Hans .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 29 (3-4) :205-214
[4]
Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal liver tandem excretory pathway for foetal bilirubin [J].
Briz, O ;
Serrano, MA ;
Macias, RIR ;
Gonzalez-Gallego, J ;
Marin, JJG .
BIOCHEMICAL JOURNAL, 2003, 371 :897-905
[5]
BROWN CDA, 2001, ATHEROSCLEROSIS, V2, P90
[6]
Efficacy and safety of rosuvastatin compared with pravastatin and simvastatin in patients with hypercholesterolemia: A randomized, double-blind, 52-week trial [J].
Brown, WV ;
Bays, HE ;
Hassman, DR ;
McKenney, J ;
Chitra, R ;
Hutchinson, H ;
Miller, E .
AMERICAN HEART JOURNAL, 2002, 144 (06) :1036-1043
[7]
Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia [J].
Campbell, SD ;
de Morais, SM ;
Xu, JHJ .
CHEMICO-BIOLOGICAL INTERACTIONS, 2004, 150 (02) :179-187
[8]
Rosuvastatin [J].
Carswell, CI ;
Plosker, GL ;
Jarvis, B .
DRUGS, 2002, 62 (14) :2075-2085
[9]
CATZ C, 1962, AM J DIS CHILD, V104, P516
[10]
Differential interaction of 3-hydroxy-3-methylglutaryl-COA reductase inhibitors with ABCB1, ABCC2, and OATP1B1 [J].
Chen, CP ;
Mireles, RJ ;
Campbell, SD ;
Lin, J ;
Mills, JB ;
Xu, JHJ ;
Smolarek, TA .
DRUG METABOLISM AND DISPOSITION, 2005, 33 (04) :537-546